Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest update is out from Lifecare AS ( (DE:LFC0) ).
Lifecare ASA, a clinical-stage medical sensor company, celebrated its listing on the Euronext Oslo Børs, marking a significant milestone towards commercializing its Continuous Glucose Monitoring systems. The company reported advancements in technology, including a fivefold increase in glucose sensitivity, and partnerships to enhance product manufacturability, positioning itself for future clinical studies and market entry, despite increased development costs.
More about Lifecare AS
Lifecare ASA is a clinical-stage medical sensor company focused on developing next-generation Continuous Glucose Monitoring (CGM) systems. Utilizing osmotic pressure as a sensing principle and Nano-granular Tunnelling Resistive sensors, their technology, known as ‘Sencell,’ is designed for monitoring various body analytes.
YTD Price Performance: 6.57%
Average Trading Volume: 297
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €17.75M
See more insights into LFC0 stock on TipRanks’ Stock Analysis page.
